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SINCE Berenblum (1941) demonstrated the power of croton oil, the expressed
or extracted oil ofthe seeds ofCroton tiglium (L.), to promote skin-tumour forma-
tion in the mouse, its use has come to have an important place in investigations
of the process of carcinogenesis. Its well-known pharmacological properties had
stimulated several attempts, some time before this, to separate the active principle
or principles. Cherbuliez and his colleagues (Cherbuliez, Ehninger and Bernhard,
1932), who review work up to that date, separated a resinous substance from the
oil by solvent partition between petroleum ether and 90 per cent methanol. This
resin was strongly vesicant; it was concentrated in the latter solvent, while most
ofthe purgative principle ofthe oil remained in the former. A further purification
of the vesicant principle was achieved by other physical procedures. Berenblum
(1941) subjected the oil to solvent partition between petroleum ether and 90 per
cent methanol, and obtained a resin from the latter solvent which was approxi-
mately ten times more potent as a promoter of skin tumour formation than the
original oil.
In the present investigation fractionation of croton oil, first by methods based
on those of Cherbuliez, and then by chromatographic analysis, was undertaken.
Fractions obtained at successive stages were tested for tumour-promoting power
by methods which have been previously described (Gwynn and Salaman, 1953).
METHIODS.
Mice.-Stock albino mice of the "S "strain (Gwynn and Salaman, 1953) were
used. They were fed on a cube diet prepared according to the Rowett Institute
formula (Thomson, 1930a and 1930b), and water ad libitum, and were 2 to 3 months
old at the beginning ofthe experiments.
Materials.-Croton oil, obtained by expression from crushed croton seeds,
was supplied by Messrs. Stafford Allen and Sons.
9: 10 dimethyl-1: 2 benzanthracene (D.M.B.A.) was supplied by Messrs.
Light & Co.
Analytical grades of organic solvents were used throughout.
Alumina (Grade II) was supplied by Messrs. Savory & Moore.
Primary treatment.-An initial application of0.2-0.3 ml. of 0-1 or 0.15 per cent
9: 10 dimethyl-1 : 2 benzanthracene (D.M.B.A.) in acetone was made to the whole
back, after the hair had been clipped.
Interval.-Before further treatment a period varying between 3 to 41 weeks
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was allowed to elapse. The exact length of this interval, in view of Berenblum
and Shubik's (1949) findings, was not considered to be critical.
Secondary treatment.-Fractions to be tested for promoting action were dissolved
in acetone, in concentrations given below, and 0.3 ml. ofthe solutions were applied
to the back of each mouse weekly, or sometimes more frequently, for periods of
9 to 19 weeks.
Conditions within eachl experiment were strictly uniform, each containing its
appropriate control, enabling quantitative comparisons to be made. The above-
mentioned variations in concentrations ofD.B.M.A. applied as primary treatment,
in the interval between primary and secondary treatments, and in the duration
andfrequency ofsecondarytreatment, occurred onlybetweendifferent experiments
where qualitative, or semi-quantitative, comparison was all that was required.
EXPERIMENTAL.
I. Preparation of Cherbuliez' resin.
The method closely followed the first part of Cherbuliez' procedure.
A weighed amount of croton oil was dissolved in approximately twice its
volume of petroleum ether (B.P. 60-80° C.), and shaken with one-half volume of
90 per cent methanol/aq. After separation the methanol layer was run off, and the
petroleum ether solution re-extracted 2 to 5 times with 90 per cent methanol. The
methanol fractions were pooled, and reduced by distillation in partial vacuum at
60° C. The last traces ofmethanol and water were removed in a vacuum dessicator
over anhydrous CaCl2. The resulting resinous material varied between 2 to 4 per
cent byweight ofthe original oil. Thepetroleum ether fraction was also evaporated
to dryness, and an oily residue remained.
In a typical experiment, from 20 g. croton oil 0.7 g. of the resin and 18-6 g. of
the oily material were obtained, i.e. yields of 3-5 per cent and 93 per cent of the
original oil respectively. These fractions were tested for promoting action by the
method described above, in concentrations corresponding approximately to the
amounts present in a 0-5 per cent solution ofthe original oil. The results are given
in Table I.
TABLE I.-Test of" Cherbuliez Resin "for Tumour-promoting Action.
Concentration
in acetone Tumour- Tumours
Yield applied Total bearing per
Substance (%). (%). tumours. mice/survivors. survivor.
Original croton oil - . 0.5 . 66 . 9/15 . 4.4
Resin . . 3.5 . 0.01 . 28 . 5/16 . 1.8
Oily residue . 93 . 0.5 . 28 . 7/14 . 2-0
Sixteen mice in each group. Primary treatment: 0-3 ml. o- 1 per cent D.M.B.A./acetone.
Interval: 5 weeks. Secondary treatment: 0-3 ml. of test solution applied to skin weekly for 11
weeks. Tumours counted at end of secondary treatment, in this and subsequent experiments.
They shew that the resin, when applied at a concentration 50 times more
dilute than the original oil, produced about half the tumour incidence. It is
probable, therefore, that the promoting agent has been considerably concentrated
in the resin, although a substantial part ofthe activity remains in the oily residue.
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II. Preparation of Cherbuliez' vesicant.
Further fractionation ofthe resinous substance obtained in the first experiment
was undertaken, by a method similar to the second part of Cherbuliez' procedure
forpreparing thevesicant material described byhim. Thepreparation ofCherbuliez
resin was carried through to the stage of removal of methanol by evaporation in
partial vacuum (see Experimental, Section I) leaving an aqueous suspension ofthe
resin. This was washed with 3 successive lots of petroleum ether. The aqueous
layer was then extracted with 5 lots ofethyl ether, and the pooled ethereal extracts
treated with 3 lots of 0.1 N aqueous NaoH, then washed 5 times with distilled
water. The ethereal layer was distilled in vacuum, and the residue taken up in
80 per cent methanol. This solution was washed with petroleum ether, freed
from alcohol as before, and the resulting aqueous suspension extracted with ethyl
ether. After removal of the ether by vacuum distillation a yellow solid foam
remained, similar to that described by Cherbuliez.
This material was tested for tumour-promoting action by the method described
above. It was strongly irritant. The maximum tolerated concentration, i.e. that
giving slight scabbing, was 0.005 per cent, and this was used. The results are
given in Table II.
TABLE II.-Test of" Cherbuliez Vesicant "for Tumour-promoting Action.
Yield as per Concentration in Total Tumour-bearing Tumours per
cent of resin. acetone applied. tumours. mice/survivors. survivor.
12% . 0.005% . 8 4/13 0.6
Sixteen mice. Primary treatment: 02 ml. 0-15 per cent D.M.B.A./acetone. Interval: 3 weeks.
Secondary treatment: O. 3 ml. of test solution applied to skin weekly for 19 weeks.
By comparing Tables I and II it will be seen that the tumourincidence resulting
from treatment with a 0-005 per cent solution ofthe vesicant was much lower than
that produced by a 0.01 per cent solution ofthe resin, in spite ofthe longer period
of application of the former (Table I). As the yield of vesicant in this experiment
was 12 per cent ofthe resin it is evident that only a small part ofthe activity ofthe
latter was retained in the vesicant.
This result suggests either that the vesicant and tumour-promoting principles
are not identical, or that this sample of the vesicant had lost a large part of its
promoting activity during preparation.
It was decided to use Cherbuliez resin, prepared as described in Experimental,
Section I, as starting material for further fractionation.
III. Chromatographic fractionation of Cherbuliez resin.
In a preliminary experiment the resin (see Experimental, Section I) dissolved
in CC14 was passed through an Alumina Column. On development a large number
of indefinite yellow zones appeared, some of which were readily washed down by
weak elutants. A more exact analysis was carried out as follows.
Two grams of resin was dissolved in CC14, and deposited on an 80 g. alumina
column made up in CC14. The column was eluted with successive 100 ml. lots of
(1) CC14 (2) 10 per cent acetone/CCl4 (3) 20 per cent acetone/CCl4.
Eluates (1) (2) and (3) were collected separately, and evaporated on the water
bath at 60° C. The column was then broken up into 4 sections, and each exhaus-
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tively extracted with methanol. The solvent was evaporated from each, and the 4
extracts numbered 1 to 4, starting from the bottom of the column. Further
details are given in Table III.
TABLE III.
Yield (in grams) Yield as
Elutant from 2 g. per cent
Fraction. or solvent. of resin. or resin.
Eluate 1 . CC14 0-140 . 70
,, 2 . . 10% acetone/CC14 . 0.023 . 11
,, 3 . . 20% acetone/CCl4 0.446 . 22.3
Extract 1 . Methanol . 0-311 15-6
,, 2 . ,, . 0.-614 . 30.7
,, 3 . . ,, . 0.111 . 5-6
,, 4 . . ,, . 0 090 . 4-5
Total recovery . .. . 735 . 86 8
Alumina Column: 80 g. 100 ml. of each elutant 1 to 3. Extracts 1 to 4 were made, after
development, from successive sections ofthe column, starting from the bottom.
In the test for tumour-promoting action, Eluates 1 and 2 were pooled, and so
were Extracts 1 and 2, and 3 and 4, respectively. They were applied as 0-02 per
cent solutions in acetone, with the exception of Eluate 3 which was applied as a
0.01 per cent solution. The results are given in Table IV.
TABLE IV.
Concentration
Yields as in acetone Tumour- Tumours
per cent applied Total bearing per
Fraction. . or resin. (%). tumours. mice/survivors. survivor.
Eluates 1 and 2 . 8-1 . 02 . 0 . 0/16 . 0
Eluate 3 . 22.3 . 0.1 . 47 . 11/16 . 30
Extracts 1 and 2 . 46 3 . 0- 2 . 37 . 9/16 . 2 3
,, 3and4 . 10.1 . 02 . 8 . 4/16 . 0 5
Sixteen mice per Fraction: Primary treatment: 0-2 ml. 0.15 per cent D.M.B.A./acetone.
Interval: 4k weeks. Secondary treatment: 0.3 ml. of test solution applied to skin weekly for
13 weeks.
Eluate 3 (20 per cent acetone/CCl4) and Extracts 1 and 2 (methanol extracts
ofthe lower halfofthe column after development) contained the bulk ofthe active
agent or agents. These fractions were therefore chosen for further study.
After some further experiment a method was evolved ofwhich the following is
an example.
Fifty-four grams of croton oil in 100 ml. of petroleum ether (B.P. 60-80° C.)
was shaken with three successive 25 ml. lots of 90 per cent methanol. The latter
were pooled, evaporated in partial vacuum at 60° C., and dried in a vacuum
dessicator over anhydrous calcium chloride for 1 day. The yield ofresin was 1.8 g.
One and a half grams of this resin was dissolved in CC14 and deposited on a
60 g. alumina column (Grade II). It was eluted with CC14, and mixtures ofCC14
and acetone containing successively higher concentrations of acetone.
No appreciable amounts ofthe material were eluted untilthe acetone concentra-
tion reached 20 per cent. Thereafter successive 50 to 100 ml. lots of 20 per cent
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acetone/CCl4 eluate were collected separately, and evaporated as described above.
These are listed, and their characteristics recorded, in Table V.
TABLE V.
Elutant.
20% acetone/CCI4
20% ,. ..
20% ,, ..
20% ,, ..
20% , ..
20% , .
20% . ..
20% . ..
50% ,. ..
50% ,. ..
Volume
of
elutant
(ml.).
100
50
50
100
100
100
100
100
100
100
Weight of Yield as
fraction. per cent
of resin.
*125 . 8.3
*285 . 19.0
*191 . 12.7
*147 . 9-8
*070 . 4- 7 *044 . 2- 9
*101 .- 6-7
*010 . 0 7
*006 . 0-4
*002 . 0.1
1.035 . 68- 6
Starting material: 1 5 g. resin. Alumina column: 60 g.
Examination of the yield in each fraction shows that the material descends in
two main blocks: the first, which is probably complex, comprises Fractions 1 to 5,
the second is mainly confined to Fraction 6.
Fraction 1 and Fraction 3, representing the front and rear parts of the first
block, and Fraction 6 representing the second block, were separately tested for
tumour-promoting action. The results are given in Table VI.
TABLE VI.
Yield as
per cent
Fraction. of resin.
1 . 8-3
3 . 9-8
6 . 6.7
Concentration
in acetone
applied
(%).
0.005
Total
tumours.
98
28
0
Tumour-
bearing
mice/survivors.
13/16
7/16
0/5
Sixteen mice per fraction. Primary treatment: 0- 2 ml. 0 15 per cent D.M.B.A./acetone.
Interval: 3 weeks. Secondary treatment: 0 3 ml. of test solution applied to skin three times per
week for 9 weeks.
They shew that the activity is carried by the first block ofeluted material, and
that the front portion of this is more active than the rear.
Having established the general conditions under which an active substance,
or group of substances, could be separated from the resin, an attempt was made
to split this material into fractions by further chromatography, using graded
elutants.
It was found that no furtherpurification could be effected by the use ofacetone/
carbon tetrachloride mixtures. Methanol/carbon tetrachloride mixtures appeared
more promising. To reduce the amounts of liquids to be handled only small
quantities of resin were subjected to chromatography. The work was simplified
by the discovery that the material eluted from the column gave a reddish yellow
colour, in very dilute solution, in presence of concentrated sulphuric acid. The
Fraction.
1
2a
2b
3
4
5
6
7
8
9
Total recovery .
Tumours
per
survivor.
6.1
1-8
0.0
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movement of the bands down the column could be followed by taking samples
of eluate at regular intervals, and adding concentrated sulphuric acid.
The following was a typical experiment: *087 g. ofresin, produced as described
in Experimental, Section I, was dissolved in about 5 ml. carbon tetrachloride and
passed over a 6 g. alumina column made up in carbon tetrachloride.
The column was then eluted, first with CC14, then with CC14/methanol mixtures
containing rising concentrations of methanol (0 to 1-2 per cent), and finally with
20 per cent acetone in CC14. Twelve successive fractions were collected. The yields
are recorded in Fig. 1.
Fractions
0.5
..b E 0'4
0. r.fi
o
C0
._ 3
II 2 13 41 5 1617 8 9 10 I11 121
I I Vol.ofEluate
%vv zuu 300
CCI4 0'425% 0.50% 0.60% 1'20% 20%
CH3OH/CC14 CH3OH/CCI4 CH3OH/CCI4CH3OH/CCI4(CH3)2CO/CCI4Elutant
FIG. 1.
There appears to be three peaks. Frequent application of the H2SO4 test
during elution suggested that a cleaner separation between these peaks had in
fact been made than appears from the dry weights recorded. Unfortunately,
though this tests reveals very small quantities of these resinous materials, the
TABLE VII.-Tests ofMethanol/CC14 Eluates of" Cherbuliez Resin"
for Tumour-promoting Activity.
Concentration
Yield as in acetone Tumour- Tumours
per cent applied Total bearing per
Sample. of resin. (%). tumours. mice/survivors. survivor.
1. (Fractions 1 and 2) . 18 . 0-008 . 0 . 0/15 0
(see Fig. 1)
2. (Fractions 4 to 7) . 51 . 0008 . 52 . 8/15 . 3.5
(see Fig. 1)
3. (Fractions 9 to 11) . 17 0.008 . 0 . 0/15 0
(see Fig. 1)
Resin . . 100 . 0.02 . 35 . 9/14 . 2 5
Fifteen mice in each group. Primary treatment: 0.2 ml. 0.15 per cent D.M.B.A./acetone. Interval: 4 weeks. Secondary treatment: 0 3 ml. of sample in acetone applied to skin 3 times a
week for 10 weeks.
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depth ofcolour is too much affected by temperature and time ofstanding to serve
as the basis for a useful quantitative colourimetric assay.
Three samples were formed by pooling Fractions 1 and 2, 4 to 7, and 9 to 11,
respectively, and tested for tumour-promoting activity. The results are given in
Table VII.
It appears that the tumour-promoting activity is confined to Sample 2. Any
activity in Samples 1 and 3 must be of a low order.
IV. Physical and chemical properties ofchromatographicfractions.
Full descriptions of these substances will be given in a later report. A few
general properties will be described here.
All the fractions eluted from alumina columns by methanol/carbon tetra-
chloride mixtures are resinous materials. Attempts to crystallize them have so
far been unsuccessful. It is unlikely that any ofthem is a pure substance. All are
insoluble in water and soluble in organic solvents. They give a reddish colour in
dilute solution on addition ofconcentrated sulphuric acid. They are slowly soluble
in 20 per cent aqueous KOH. They take up bromide in CC14 solution in the cold;
further bromine is taken up on heating, with the liberation of HBr. The iodine
number determined by the pyridine dibromide method (Hodgson-Jones and
Wheatley, 1952) is variable, but is usually about 50 cg. per g. The active fractions
(Eluates 4 to 7, Fig. 1) form white friable foamy deposits on evaporation of the
solvent, while the inactive fractions have the appearance of very viscous liquids.
All the samples tested for tumour-promoting activity (Table VII) cause
hyperplasia ofthe epidermis ofapproximately equal severity at similar concentra-
tions.
DISCUSSION.
Berenblum (1944, 1954) has speculated on the nature of tumour-promotion
by croton oil and other substances. He points out that of many agents which
induce hyperplasia, only a few are tumour-promoting, and therefore that the
tumour-promoting action of croton oil cannot depend only on its ability to induce
hyperplasia.
However no tumour-promoting agent has yet been discovered which does not
also induce hyperplasia ofthe tissue concerned. Iodo-acetic acid and chloroaceto-
phenone, for instance, previously shown in this laboratory to be tumour-promoting
in mouse skin (Gwynn and Salaman, 1953), also induce epidermal hyperplasia.
In a recent report Daneel and Wissenfels (1955) describe the separation of croton
oil, by a chromatographic method, into irritant and non-irritant fractions. They
claim that only the non-irritant fraction is tumour-promoting when applied to
mouse skin previously treated with methylcholanthrene. The validity of this
claim is difficult to assess because of the small number of mice used, and because
the criterion for assessment of the irritant property (entziindlichen Wirkung) is
not stated. Their work is being repeated in this laboratory.
As judged by microscopical appearance all the croton oil fractions examined in
the present work produced hyperplasia ofthe epidermis, i.e. this property was not
confined to the tumour-promoting fractions.
Further work will be needed before the relation between hyperplasia and
tumour-promotion is made clear.
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The active fraction which has been separated from croton oil is tumour-
promoting in mouse skin in far higher dilution than any other substance known.
It is therefore important to determine its chemical nature. Efforts to do this have
met with considerable difficulties, but are being continued.
SUMMARY.
The tumour-promoting substance present in croton oil has been concentrated
by solvent partition followed by chromatographic analysis. The product obtained,
a white amorphous solid, is very much more potent as a tumour-promoter (about
fifty times) than the original oil. Some properties of this substance are described.
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